EvoEndo Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide
EvoEndo, Inc. has announced that over 3,000 sedation-free transnasal endoscopy procedures have been completed using their Endoscopy System, with implementation expanding to over 70 locations across the country. CEO Jonathan Hartmann emphasized the significance of this milestone for patients, families, and physicians, highlighting improved access to sedation-free procedures.
CHICAGO–(BUSINESS WIRE)– #FEEES–EvoEndo®, Inc. (EvoEndo) today announced that practitioners have now completed more than 3,000 sedation-free transnasal endoscopy (TNE) procedures using the EvoEndo Endoscopy System, as implementation expands to more than 70 locations nationwide. “Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, CEO of EvoEndo. “Every case reflects greater access to sedation-free